Neurologic and metabolic issues in moderately preterm, late preterm, and early term infants

Abbot R Laptook1

  • 1Department of Pediatrics, Women & Infants Hospital of Rhode Island, The Warren Alpert Medical School of Brown University, 101 Dudley Street, Providence, RI 02905, USA.

Clinics in Perinatology
|November 5, 2013
PubMed

Insights

Neurologic issues like brain bleeds are rare in moderately preterm infants. Feeding difficulties, however, are the main concern, stemming from challenges in coordinating suck, swallow, and breathing.

Area of Science:

  • Neonatal neurology
  • Developmental pediatrics

Background:

  • Very preterm and extremely preterm infants face significant neurologic risks, including intracranial hemorrhage, white matter injury, and apnea.
  • These severe morbidities are less frequent in moderately preterm and late preterm infants.

Purpose of the Study:

  • To investigate the spectrum and frequency of neurologic morbidities in moderately and late preterm infants.
  • To identify the primary neurologic challenges faced by these infants.

Main Methods:

  • Review of existing literature and surveillance data on neuroimaging in preterm infants.
  • Analysis of reported frequencies of specific neurologic conditions.
  • Identification of feeding difficulties as a key outcome measure.

Main Results:

  • Germinal matrix hemorrhage-intraventricular hemorrhage and white matter injury occur infrequently in moderately and late preterm infants, though precise frequencies are difficult to ascertain due to selection bias in neuroimaging.
  • Feeding difficulties, related to the integration of suck, swallow, and breathing, represent the most common neurologic morbidity in this population.

Conclusions:

  • While severe neurologic injuries are uncommon, moderately and late preterm infants frequently experience feeding challenges.
  • The developmental integration of suck, swallow, and breathing is a critical factor in the neurologic well-being and feeding success of these infants.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K